Cited by 24Inflammatory Myopathies and DermatomyositisInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related Diseases

Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody

Open access
Kishaba, Tomoo, McGill, Rita, Nei, Yuichiro, Ibuki, Sachi, Momose, Masashi, Nishiyama, Kenta, Nagano, Hiroaki, Yamashiro, Shin·2018·The Journal of Medical Investigation

Abstract

BACKGROUND: Dermatomyositis (DM) and polymyositis (PM) often have association with interstitial lung disease (ILD) which have disease specific autoantibody. METHODOLOGY: We reviewed medical records of DM/PM associated ILD from January 2000 to December 2017 according to the autoantibody. RESULT: We identified 52 patients, of whom 30 were antibody negative, 18 had anti aminoacyl-tRNA synthetases (ARS) antibodies and 4 had anti melanoma differentiation-associated gene (MDA)-5 antibody. In high resolution computed tomography (HRCT) of the chest, area of ground glass opacity (GGO), consolidation, and lung tip consolidation were more extensive in anti MDA-5 antibody positive patients (p=0.051, p=0.026, and p=0.027, respectively). Among laboratory findings, GOT had strong correlations with CPK (r=0.889, p < 0.001), and LDH (r=0.910, p < 0.001). Among roentgenographic findings, there were moderate correlations between GGO and consolidation (r=0.668, p < 0.001), and between reticular shadow and traction bronchiectasis (p=0.633, p < 0.001). ILD patients with anti MDA-5 antibodies had decreased survival (1.00 vs 84.3, 22.9 months, p < 0.001). CONCLUSION: ILD patients with anti ARS antibody had intense inflammation, but reversible fibrosis and good prognosis. On the other hand, anti MDA-5 antibody positive ILD patients had shorter survival. Extent of parenchymal shadow and serum GOT were useful indicator of disease activity of PM/DM associated ILD patients in our cohort. J. Med. Invest. 65:251-257, August, 2018.

Integrity signals

Registry

Crossref · 10.2152/jmi.65.251

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some studies have shown no notable effects of anti-fibrotic agents on wounds, anastomosis, or bleeding.

    “some studies have shown no notable effects of anti-fibrotic agents on wounds, anastomosis, or bleeding [51-53].”

    From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [52]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kishaba, T., McGill, R., Nei, Y., Ibuki, S., Momose, M., Nishiyama, K., Nagano, H., & Yamashiro, S.
Affiliations
  • Okinawa Prefectural Chubu Hospital (JP)
  • University of Chicago (US)
  • Kyoto University (JP)
Venue
The Journal of Medical Investigation
Published
2018
Volume
65
Issue
3.4
Pages
251-257
ISSN
  • 1343-1420 (ISSN-L)
  • 1349-6867
OpenAlex
W2894769425
Cited by
24
References
25
Citations by year
2025: 1 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 1
FWCI
2.35
Type
journal article
Language
en
Open access
Locations
  • The Journal of Medical Investigation (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Inflammatory Myopathies and Dermatomyositis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
Keywords
dermatomyositis, polymyositis, interstitial lung disease, anti-MDA5 antibodies, autoantibody classification, ground-glass opacities, lung consolidation, serum GOT, creatine kinase, lactate dehydrogenase, survival, disease activity markers
MeSH terms
Interferon-Induced Helicase, IFIH1, Adolescent, Adult, Aged, Aged, 80 and over, Amino Acyl-tRNA Synthetases, Antibody Specificity, Autoantibodies, Dermatomyositis, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Polymyositis, Lung Diseases, Interstitial, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review